Jefferies Group’s Mead Johnson Nutrition Company MJN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-213,200
Closed -$19M 2819
2017
Q1
$19M Buy
213,200
+189,200
+788% +$15.6M 0.14% 117
2016
Q4
$1.7M Buy
+24,000
New +$1.79M 0.01% 1007
2016
Q2
Sell
-130,900
Closed -$11.1M 2633
2016
Q1
$11.1M Sell
130,900
-112,600
-46% -$8.38M 0.06% 231
2015
Q4
$19.2M Buy
243,500
+213,300
+706% +$16.8M 0.11% 149
2015
Q3
$2.13M Buy
+30,200
New +$2.48M 0.01% 869
2014
Q3
Sell
-35,000
Closed -$3.26M 2624
2014
Q2
$3.26M Buy
+35,000
New +$3.06M 0.03% 461
2014
Q1
Sell
-4,600
Closed -$385K 2554
2013
Q4
$385K Sell
4,600
-64,600
-93% -$5.26M ﹤0.01% 1262
2013
Q3
$5.14M Buy
+69,200
New +$5.19M 0.05% 320

Other funds holding MJN

Jefferies Group's MJN Position: Q1 2017 in Review

Jefferies Group sold out of Mead Johnson Nutrition Company (MJN) in Q1 2017, closing a stake of 35,574 shares — an estimated $2.93M sold.

Jefferies Group first reported a position in MJN in Q2 2013 and held it in 11 quarters. The position peaked at $6.77M in Q2 2015. 533 funds tracked by Wall St. Rank hold MJN as of Q1 2017.

  • Jefferies Group reported no remaining Mead Johnson Nutrition Company position as of Q1 2017 after selling out during the quarter.
  • Jefferies Group sold 35,574 Mead Johnson Nutrition Company shares in Q1 2017, an estimated $2.93M.
  • Jefferies Group first reported a position in Mead Johnson Nutrition Company in Q2 2013 and held it in 11 quarters.
  • Jefferies Group's Mead Johnson Nutrition Company position peaked at $6.77M in Q2 2015.
  • 533 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q1 2017.

Based on Jefferies Group's 13F filing for Q1 2017, filed 15 May 2017.